ERLOTINIB 150 mg (Erlonat) x 30 Tablets

Uses of ERLOTINIB 150 mg

• Treats non-small cell lung cancer (NSCLC)
• Treats advanced pancreatic cancer (with gemcitabine)
• Used in patients with EGFR-positive cancers
• Helps slow cancer progression
• Part of targeted cancer therapy

Benefits

• Targets cancer cells specifically
• Slows tumour growth
• Delays disease progression
• May improve treatment outcomes
• Convenient once-daily oral therapy

How Does ERLOTINIB 150 mg Work?

Erlotinib is an EGFR (epidermal growth factor receptor) inhibitor. It blocks the EGFR protein on cancer cells, preventing signals that promote cell growth and division. This slows the growth and spread of cancer cells and helps control the progression of the disease.

Side Effects

• Skin rash
• Diarrhoea
• Nausea
• Fatigue
• Loss of appetite
• Dry skin
• Mouth sores
• Eye irritation

Precautions

• Take the medicine on an empty stomach, as directed by your doctor.
• Avoid smoking, as it can reduce the effectiveness of Erlotinib.
• Inform your doctor if you have liver disease, kidney disease, or lung disorders.
• Protect your skin from excessive sunlight during treatment.
• Tell your healthcare provider about all medicines and supplements you are taking.
• Seek medical attention if you develop severe diarrhoea, breathing difficulties, or vision problems.
• Attend regular follow-up visits and blood tests to monitor your response to treatment.